A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARE
Part of paid clinical trials in Columbus, Ohio.
- Sponsor
- Ohio State University
- Study ID
- NCT05909046
- Status
- Recruiting
Conditions
- Gestational Diabetes
- Gestational Diabetes Mellitus in the Puerperium
- Pre-Gestational Diabetes
- Pregnancy in Diabetic
- Pregnancy, High Risk
- Type2diabetes
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Immediate inpatient postpartum OGTT — DIAGNOSTIC_TESTThe intervention includes immediate inpatient postpartum 2-hour oral glucose tolerance test (OGTT) prior to delivery discharge
- Standard of care 4-12 week postpartum OGTT — DIAGNOSTIC_TESTStandard of care is 4-12 week outpatient postpartum OGTT
Study Details
DIP : To conduct a pragmatic, non-blinded randomized controlled trial (pRCT) of immediate in-patient postpartum OGTT prior to delivery discharge (intervention) versus 4-12 week outpatient postpartum OGTT (current standard care) to improve the frequency of post-partum diabetes screening among individuals with a pregnancy complicated by GDM. Follow up PP CARE: To engage with individuals with a history of GDM through a patient-centered mixed-methods survey and qualitative assessment to evaluate the barriers to and facilitators of Cardiovascular health (CVH) counseling and risk-reduction postpartum at the patient and healthcare system levels inclusive of Social determinants of health (SDOH) and structural factors, as well as patient preferences and perspectives on CVH and wellness interventions
Key Dates
- Start date
- Jul 24, 2023
- Status verified
- Nov 2025
- Primary completion
- Jun 30, 2026
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 104 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Active Comparator: Immediate inpatient postpartum OGTTThe intervention includes immediate inpatient postpartum 2-hour oral glucose tolerance test (OGTT) prior to delivery discharge
- Other: Standard of careStandard of care is 4-12 week outpatient postpartum OGTT
Primary Outcome Measure
Rate of postpartum diabetes mellitus screening [ Time Frame: From delivery to up to 12 weeks postpartum ]
Central Contacts
- Kartik Venkatesh, MD, PhD614-293-2222
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine | Columbus | Ohio | 43210 |
Find similar trials in Columbus, OH
Related Studies
- PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 DiabetesPHASE4 · Recruiting · Brigham and Women's Hospital · Huntsville, Alabama
- Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and CoachingRecruiting · Ohio State University · Columbus, Ohio
- Promoting Alternatives to Sulfonylureas to Improve Patient Safety in Type 2 DiabetesRecruiting · Ian J. Neeland, MD · Cleveland, Ohio
- PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early LifeRecruiting · University of Colorado, Denver · Aurora, Colorado